Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.
about
Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Resource utilization and costs ...... benign prostatic hyperplasia.
@en
type
label
Resource utilization and costs ...... benign prostatic hyperplasia.
@en
prefLabel
Resource utilization and costs ...... benign prostatic hyperplasia.
@en
P2093
P2860
P1433
P1476
Resource utilization and costs ...... benign prostatic hyperplasia.
@en
P2093
Ana Mª Mora
Antoni Sicras-Mainar
Marta Hernández
Ruth Navarro-Artieda
P2860
P2888
P356
10.1186/S12894-017-0275-6
P577
2017-09-12T00:00:00Z
P6179
1091612642